epigallocatechin gallate has been researched along with Endometriosis in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Chen, FY; Deng, YZ; Guo, ZX; Tang, RY; Wang, X; Yu, Q | 1 |
Guan, QH; Li, L; Shi, WJ; Tao, AL; Zhou, LS | 1 |
Kamal, DAM; Mokhtar, MH; Salamt, N; Zaid, SSM | 1 |
Darcha, C; Matsuzaki, S | 1 |
Chakravarty, B; Chaudhury, K; Singh, AK | 1 |
Laschke, MW; Menger, MD; Scheuer, C; Schwender, C; Vollmar, B | 1 |
Becker, CM; Birsner, AE; Chu, CY; D'Amato, RJ; Davis, TN; Kung, AL; Lui, WT; Wai Man, GC; Wang, CC; Xu, H | 1 |
Chan, TH; Cheng, JT; Chu, CY; Chu, KO; He, YX; Kwong, J; Lau, TS; Li, G; Man, GC; Qin, L; Wang, CC; Xu, H; Zhang, T | 1 |
Barañao, RI; Bastón, JI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG; Singla, JJ | 1 |
2 review(s) available for epigallocatechin gallate and Endometriosis
Article | Year |
---|---|
New therapeutic approaches for endometriosis besides hormonal therapy.
Topics: Animals; Catechin; Endometriosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Resveratrol; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2019 |
Beneficial Effects of Green Tea Catechins on Female Reproductive Disorders: A Review.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Cell Proliferation; Corticosterone; Cross-Sectional Studies; Disease Models, Animal; Dysmenorrhea; Endometriosis; Female; Humans; Mice; Plant Extracts; Polycystic Ovary Syndrome; Tea; Uterus | 2021 |
7 other study(ies) available for epigallocatechin gallate and Endometriosis
Article | Year |
---|---|
Effect of epigallocatechin-3-gallate on the status of DNA methylation of E-cadherin promoter region on endometriosis mouse.
Topics: Animals; Cadherins; Catechin; DNA Methylation; Endometriosis; Female; Humans; Mice; Mice, Nude; Promoter Regions, Genetic | 2020 |
Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.
Topics: Acetylcysteine; Actins; Adult; Animals; Catechin; Cell Movement; Cell Proliferation; Cells, Cultured; Connective Tissue Growth Factor; Endometriosis; Female; Fibronectins; Fibrosis; Humans; Matrix Metalloproteinase 2; Mice; Mice, Nude; Peptide Fragments; Signal Transduction | 2014 |
Nanoparticle-Assisted Combinatorial Therapy for Effective Treatment of Endometriosis.
Topics: Animals; Antioxidants; Catechin; Cells, Cultured; Doxycycline; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endometriosis; Female; Humans; Mice; Nanoparticles; Spectroscopy, Fourier Transform Infrared; Treatment Outcome | 2015 |
Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
Topics: Angiogenesis Inhibitors; Animals; Catechin; Cell Line; Cell Proliferation; Cricetinae; Endometriosis; Endometrium; Estradiol; Female; Gene Expression; Ovarian Follicle; Vascular Endothelial Growth Factor A | 2008 |
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Topics: Adult; Animals; Catechin; Cells, Cultured; Endometriosis; Female; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Random Allocation; Signal Transduction; Tea; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biological Availability; Catechin; Endometriosis; Endometrium; Female; Mice; Neovascularization, Pathologic; Ovarian Follicle; Oxidation-Reduction; Prodrugs; Tea | 2013 |
Natural therapies assessment for the treatment of endometriosis.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Humans; Injections, Intraperitoneal; Intestinal Diseases; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Resveratrol; Stilbenes | 2013 |